tiprankstipranks
GT Biopharma (GTBP)
NASDAQ:GTBP
US Market
GTBP
GT Biopharma
RESEARCH TOOLSreports
Want to see GTBP full AI Analyst Report?

GT Biopharma (GTBP) Income Statement

324 Followers

GT Biopharma Income Statement

Last quarter (Q4 2025), GT Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, GT Biopharma's net income was $-23.03M. See GT Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 12.42M$ 14.36M$ 13.58M$ 21.26M$ 57.52M
Depreciation and Amortization
$ 0.00$ 0.00$ 13.58M$ 0.00$ 0.00
EBITDA
$ -34.32M$ -13.16M$ 5.98M$ -20.96M$ -57.48M
Operating Income
$ -12.42M$ -14.36M$ -13.58M$ -21.26M$ -57.52M
Other Income/Expenses
$ -15.93M$ 1.20M$ 5.98M$ 373.00K$ -498.00K
Pretax Income
$ -28.35M$ -13.16M$ -7.60M$ -20.88M$ -58.01M
Net Income
$ -28.35M$ -13.16M$ -7.60M$ -20.88M$ -58.01M
Per Share Metrics
Basic EPS
$ -6.25$ -6.94$ -5.64$ -0.66$ -2.06
Diluted EPS
$ -6.25$ -6.94$ -5.64$ -0.66$ -2.06
Weighted Average Shares Outstanding
 5.51M 1.90M 1.35M 31.87M 28.16M
Weighted Average Shares Outstanding (Diluted)
 5.51M 1.90M 1.35M 31.87M 28.16M
Currency in USD

GT Biopharma Earnings and Revenue History